Overview

Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the efficacy and safety of cabergoline in prevention of ovarian hyperstimulation syndrome versus albumin in ART program.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Royan Institute

Treatments:

Cabergoline